Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-29FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA granted supplemental approval for zolpidem tartrate submitted by Lupin Pharmaceuticals, Inc. under an ANDA.
-
FDA approval · 2019-11-29FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic zolpidem tartrate product (ANDA 204299). Zolpidem tartrate is…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Melatonin for Circadian Sleep Disorders in the Blind [NA]
Clinical trial update on melatonin for circadian sleep disorders in the blind; study terminated with results posted in 2019.
-
FDA approval · 2019-11-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Zolpidem Tartrate submitted by Sandoz Inc.
-
FDA approval · 2019-11-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for zolpidem tartrate submitted by Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-11-15FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for zolpidem tartrate by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2019-11-12FDA Approved: ESZOPICLONE — Supplemental Application (Glenmark Pharmaceuticals Inc. USA)
The FDA approved a supplemental application for Eszopiclone submitted by Glenmark Pharmaceuticals Inc. USA.
-
FDA approval · 2019-11-07FDA Approved: ESZOPICLONE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for eszopiclone (generic), a sleep medication used to treat insomnia. This actio…
-
FDA approval · 2019-11-04FDA Approved: ESZOPICLONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application from Mylan Pharmaceuticals for eszopiclone (generic), under ANDA 091151, to support the marketin…
-
FDA approval · 2019-11-04FDA Approved: ESZOPICLONE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Eszopiclone from Aurobindo Pharma Limited, authorizing a generic version of the prescription…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs [Phase 4]
Phase 4 trial comparing Belsomra at 10 mg and 20 mg to placebo in non-elderly adults with insomnia completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: The Role of Tapering Pace and Selected Traits on Hypnotic Discontinuation [Phase 2]
Phase 2 trial investigating how tapering pace and certain traits influence discontinuation of hypnotics in individuals with hypnotic depende…
-
FDA approval · 2019-10-25FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for zolpidem tartrate submitted by Chartwell RX, LLC.
-
FDA approval · 2019-10-21FDA Approved: ZALEPLON — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Zaleplon submitted by Bionpharma Inc. The approval confirms continued marketing of the generic d…
-
FDA approval · 2019-10-21FDA Approved: ZALEPLON — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for the generic sleep aid Zaleplon from Hikma Pharmaceuticals USA Inc., authorizing a modificati…
-
FDA approval · 2019-10-17FDA Approved: ZALEPLON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Zaleplon submitted by Rising Pharma Holdings, Inc.
-
FDA label_change · 2019-10-09FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for HALCION (triazolam) from Pharmacia & Upjohn Company LLC, resulting in changes to the product lab…
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Polysomnographic Study Comparing the Use of Dexmedetomidine and Zolpidem to Induce Natural Sleep [NA]
Clinical trial comparing dexmedetomidine vs zolpidem for inducing natural sleep in insomnia; study completed with results posted.
-
FDA approval · 2019-10-03FDA Approved: ZALEPLON — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Zaleplon from Unichem Pharmaceuticals (USA), Inc., under the existing ANDA.
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Choosing Options for Insomnia in Cancer Effectively (CHOICE): A Comparative Effectiveness Trial of Acupuncture and Cognitive Behavior Therapy [NA]
A completed comparative effectiveness trial comparing acupuncture and cognitive behavioral therapy for insomnia in cancer patients with post…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic [Phase 1, Phase 2]
Phase 1/2 clinical trial exploring oral dexmedetomidine as a sleep therapeutic for insomnia completed with results posted in 2019.
-
FDA approval · 2019-09-30FDA Approved: TEMAZEPAM — Supplemental Application (Actavis Pharma, Inc.)
FDA approves a supplemental application for Temazepam from Actavis Pharma, Inc.
-
FDA approval · 2019-09-20FDA Approved: TEMAZEPAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for temazepam filed by Ascend Laboratories, LLC.
-
FDA approval · 2019-09-19FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for zolpidem tartrate from NorthStar Rx LLC, granting approval for the generic insomnia medication. …
-
CLINICAL_TRIALS trial_result · 2019-08-28Clinical Trial Update: Sequenced Therapies for Comorbid and Primary Insomnias [NA]
Clinical trial update on sequenced therapies for insomnia, including comorbid psychiatric disorder and primary insomnia; status completed wi…